LATESTSEARCH ⌕
NASDAQ / LIVE COMPANY INTELLIGENCE

eXoZymes Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKEREXOZ
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / EXOZ COVERAGE

What’s moving eXoZymes Inc. now

Current reporting with the operating signal separated from the noise.

01
eXoZymes Inc. Announces Closing of $6 Million Public Offering

eXoZymes Inc. Announces Closing of $6 Million Public Offering

The story matters when it changes eXoZymes Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
02
eXoZymes Inc. Announces Pricing of Public Offering of Common Stock and Warrants

eXoZymes Inc. Announces Pricing of Public Offering of Common Stock and Warrants

Investors are testing whether eXoZymes Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
03
eXoZymes Inc. Partners With B2i Digital to Spotlight the Cell-Free Next Generation of Biomanufacturing

eXoZymes Inc. Partners With B2i Digital to Spotlight the Cell-Free Next Generation of Biomanufacturing

The story matters when it changes eXoZymes Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
04
eXoZymes Inc.

eXoZymes Inc.

The story matters when it changes eXoZymes Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
05
eXoZymes Inc. Introduces 'Exozymes' Terminology in Cover Story of GEN Biotechnology to Advance Cell-Free Biomanufacturing

eXoZymes Inc. Introduces 'Exozymes' Terminology in Cover Story of GEN Biotechnology to Advance Cell-Free Biomanufacturing

The story matters when it changes eXoZymes Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
06
eXoZymes and MDB Capital Announce Leadership Transition at eXoZymes Inc.

eXoZymes and MDB Capital Announce Leadership Transition at eXoZymes Inc.

The story matters when it changes eXoZymes Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
07
eXoZymes Inc. to Ring Nasdaq Closing Bell Following Successful IPO

eXoZymes Inc. to Ring Nasdaq Closing Bell Following Successful IPO

The story matters when it changes eXoZymes Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest EXOZ filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-14 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-13 · Period 2025-09-30SEC ↗10-KAnnual financial reportFiled 2026-03-30 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-07-01 · Period 2026-06-30SEC ↗8-KMaterial company eventFiled 2026-06-26 · Period 2026-06-25SEC ↗8-KMaterial company eventFiled 2026-06-17 · Period 2026-06-17SEC ↗DEF 14AProxy and shareholder meetingFiled 2025-06-20 · Period 2025-07-25SEC ↗424B5Official SEC filingFiled 2026-06-30SEC ↗
EARNINGS / QUARTERLY TRACKER

eXoZymes Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.